Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2003
08/28/2003CA2477117A1 Pyrrolopyrimidine derivative
08/28/2003CA2477116A1 Pyrrolopyrimidine derivatives
08/28/2003CA2477014A1 Rna interference mediated inhibition of tnf and tnf receptor superfamily gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476935A1 Drug delivery system for subconjunctival administration of fine particles
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476679A1 Vitamin d3 derivatives and remedies using the same
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476452A1 Electroporation methods for introducing bioactive agents into cells
08/28/2003CA2476438A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475879A1 Synthesis of quinazolinones
08/28/2003CA2475437A1 Methods for producing .gamma..delta. t cells
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2471421A1 Rna interference mediated inhibition of protein typrosine phosphatase-1b (ptp-1b) gene expression using short interfering nucleic acid (sina)
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/27/2003EP1338605A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres
08/27/2003EP1338592A1 Novel 2-phenylpiperazine derivatives
08/27/2003EP1337636A2 Soluble zcytor 11 cytokine receptors
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337526A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/27/2003EP1337521A1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337268A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
08/27/2003EP1337261A1 Anti-inflammatory and healing medicine based on laminarin sulphate
08/27/2003EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1189617B1 Pharmaceutical combination with analgesic action containing paracetamol and buspirone
08/27/2003EP1183047B1 Pharmaceutical preparation
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0942740B1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003EP0739342B1 Pyridine modulators of acetylcholine receptors
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439012A 2-zminoalkyl-thieno [2,3-D] pyrimidines
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438998A Quinolinyl and benzothiazolyc PPAR-gamma modulators
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438892A Low carbony drate compositions, kits thereof, and methods of use
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438887A 水性液体制剂 The aqueous liquid preparation
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438878A Topical pharmaceutical formulations and methods of treatment
08/27/2003CN1438873A Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1438009A Method for making capsule for promoting blood-circulation and relieving pain
08/27/2003CN1438001A Medicine for treating rheumatism disease
08/27/2003CN1438000A Medicine for treating rheumatism and preparation method
08/27/2003CN1437998A Oral liquor for treating rheumatism
08/27/2003CN1437997A Internal organs toxicant-eliminating pill and preparation method
08/27/2003CN1437983A Plaster for treating dysmenorrhoea and preparation method
08/27/2003CN1437981A Alose pain-relieving atomising agent
08/27/2003CN1437968A Heat-clearing and stagnation-dissipating particle medicine and preparation method
08/27/2003CN1437967A Medicine for treating appendicitis
08/27/2003CN1437958A Medicated food for treating rheumarthritis and preparation method thereof
08/27/2003CN1437953A Gentiamarin powder infection for muscle injection and intravenous injection
08/27/2003CN1437939A Method for induding andrographolide by cyclodextrin and medicinal preparation
08/27/2003CN1119348C Glucocorticoid derivatives, their composition and use
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119344C Heterocyclic substed, pyrrolidine amide derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
08/27/2003CN1119313C Inhibition of matrix metallo proteases by 2-(omega-aroylalkyc)-4-biaryl-oxobutyric acids
08/27/2003CN1119161C Medicine for treating rheumatisms
08/27/2003CN1119147C Kappa-opiate agonists for inflammatory bowel disorders
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610745 Use of 2-hydroxy-4-trifluoromethyl-benzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-KS
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610739 Amide and ester derivatives
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610724 3-Aminopyrazole inhibitors of cyclin dependent kinases
08/26/2003US6610718 And dosage forms for treating rheumatoid arthritis
08/26/2003US6610717 Selectively inhibits action of N-type calcium channel; treatment of ischemic cerebrovascular disorders caused by cerebral infarction or intracerebral bleeding, Alzheimer's disease, AIDS related dementia, Parkinson's disease
1 ... 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 ... 1272